We are excited to announce that the results of Mymee's pilot study in Lupus have just been published in proceedings of the 42nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). Mymee demonstrated clinically meaningful, statistically significant improvements in several dimensions of quality of life in people with Lupus who completed the digital care program.
Acceptance by EMBC, the world's largest international biomedical engineering conference, is an honor and just one step in Mymee's plans for increasing the publication of clinical results in peer-reviewed journals.
Dr. Nicole Bundy, Chief Medical Officer at Mymee said, "We are driven to continue validating our program and achieving recognition for the results. We've seen life-changing improvements across the spectrum of autoimmune diseases, and now with publications like this, we can broaden the awareness of the Mymee program in the medical community and reach more patients in need." Stay tuned for even more publications including our successful randomized controlled trial that has been completed since.
You can request an advanced copy of the clinical pilot study submitted to EMBC below.
